Several members of the FXYD family have been linked to major human diseases, including heart failure (FXYD1), hypomagnesemia (FXYD2), cancer (FXYD3, FXYD5), and schizophrenia (FXYD6), making them attractive specific targets for future therapies. Here, FXYD2 is linked to familial primary hypomagnesemia.